Related Experiment Video
Updated: Jun 11, 2026
07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
[Papillary thyroid microcarcinomas: review of 230 cases]
A Bozec1, I Peyrottes, G Poissonnet
1Institut Universitaire de la Face et du Cou, Centre Antoine-Lacassagne, département de Chirurgie, 33 avenue de Valombrose, 06189 Nice, France. alexandre.bozec@nice.fnclcc.fr
Revue De Laryngologie - Otologie - Rhinologie
|July 6, 2010
Summary
Papillary microcarcinoma (PMC) is a common thyroid cancer. Tumor size correlates with aggressiveness, and radioiodine therapy is increasingly reduced due to PMC's good prognosis.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Context:
- Papillary microcarcinoma (PMC) represents a frequent pathological subtype of thyroid cancer.
- Understanding PMC's diagnostic, clinical, and pathological features is crucial for effective management.
Purpose:
- To describe the diagnostic circumstances, clinical and pathological characteristics of PMC.
- To analyze therapeutic management and compare it with current guidelines.
- To investigate correlations between pathological parameters and patient/tumor factors.
Summary:
- A retrospective study of 230 PMC patients (2000-2006) investigated diagnostic timing, tumor characteristics, and treatment outcomes.
- PMC diagnosis was preoperatively suspected in 15% and intraoperatively confirmed in 42%.
- Tumor size correlated with plurifocality, bilaterality, and lymph node metastasis (p < 0.05). Postoperative radioiodine therapy indications decreased by approximately 50% over the study period, with no PMC-related deaths.
Impact:
- Tumor size is a significant indicator of aggressiveness even in small thyroid cancers.
- The study supports a reduced role for radioiodine therapy in PMC management due to its favorable prognosis.
- Findings inform clinical decision-making and adherence to updated treatment guidelines for thyroid PMC.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...